BR112023000264A2 - Método para aumentar a população de coprococcus spp. no microbioma intestinal - Google Patents

Método para aumentar a população de coprococcus spp. no microbioma intestinal

Info

Publication number
BR112023000264A2
BR112023000264A2 BR112023000264A BR112023000264A BR112023000264A2 BR 112023000264 A2 BR112023000264 A2 BR 112023000264A2 BR 112023000264 A BR112023000264 A BR 112023000264A BR 112023000264 A BR112023000264 A BR 112023000264A BR 112023000264 A2 BR112023000264 A2 BR 112023000264A2
Authority
BR
Brazil
Prior art keywords
population
increase
coprococcus spp
coprococcus
spp
Prior art date
Application number
BR112023000264A
Other languages
English (en)
Inventor
Pham Thanh-Van
Rehman Ateequr
Seifert Nicole
Steinert Robert
SYBESMA Wilbert
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BR112023000264A2 publication Critical patent/BR112023000264A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

MÉTODO PARA AUMENTAR A POPULAÇÃO DE COPROCOCCUS SPP. NO MICROBIOMA INTESTINAL. A população de bactérias Coprococcus spp. no microbioma intestinal é menor em pessoas com várias doenças. Foi constatado que a administração de vitaminas/combinações de vitaminas, tais como: a combinação de vitamina B2 e C; vitamina D3; betacaroteno e vitamina B5, quando administrados diretamente no intestino, de modo a fornecer nutrição diretamente ao microbioma intestinal, podem resultar em um aumento de Coprococcus spp.
BR112023000264A 2020-07-09 2021-07-08 Método para aumentar a população de coprococcus spp. no microbioma intestinal BR112023000264A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20184915 2020-07-09
PCT/EP2021/068934 WO2022008632A1 (en) 2020-07-09 2021-07-08 Method of increasing the population of coprococcus spp. in the gut microbiome

Publications (1)

Publication Number Publication Date
BR112023000264A2 true BR112023000264A2 (pt) 2023-01-31

Family

ID=71574988

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023000264A BR112023000264A2 (pt) 2020-07-09 2021-07-08 Método para aumentar a população de coprococcus spp. no microbioma intestinal

Country Status (7)

Country Link
US (1) US20230255930A1 (pt)
EP (1) EP4178583A1 (pt)
JP (1) JP2023533191A (pt)
KR (1) KR20230038225A (pt)
CN (1) CN115768435A (pt)
BR (1) BR112023000264A2 (pt)
WO (1) WO2022008632A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100500652C (zh) * 2007-02-12 2009-06-17 浙江大学 一种高全反式β-胡萝卜素制剂的制备方法
EP3209803A4 (en) * 2014-10-21 2018-06-13 Ubiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics
CN105521480A (zh) * 2016-01-07 2016-04-27 天津市康瑞药业有限公司 一种适用于10岁以下儿童的复合维生素片
CA3040552A1 (en) * 2016-04-19 2017-10-26 Conaris Research Institute Ag Shellac microcapsule formulations and compositions for topical intestinal delivery of vitamin b3
JP2021535086A (ja) * 2018-08-29 2021-12-16 ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. 腸の健康を改善するための製剤

Also Published As

Publication number Publication date
CN115768435A (zh) 2023-03-07
WO2022008632A1 (en) 2022-01-13
KR20230038225A (ko) 2023-03-17
JP2023533191A (ja) 2023-08-02
US20230255930A1 (en) 2023-08-17
EP4178583A1 (en) 2023-05-17

Similar Documents

Publication Publication Date Title
Karkos et al. Spirulina in clinical practice: evidence‐based human applications
BR112012033666A2 (pt) formulações para alimentação por tubo e métodos de uso das mesmas
WO2007112996A3 (en) Use of compounds and combinations of compounds for improving the physical appearance
BR112013000027A2 (pt) tratamento de distúrbios cognitivos
BR112021022139A2 (pt) Preparação de canabidiol, e, método para tratar um paciente que sofre de espasmos epilépticos
BR112017025339A2 (pt) composições nutricionais contendo um nível elevado de inositol e usos das mesmas
AR106644A1 (es) Composiciones nutricionales sinergísticas y usos de las mismas
BR112017014649A2 (pt) ?isolado intestinal humano, e, composição?
AR110060A1 (es) Composiciones nutricionales que proporcionan el manejo dietético de cólicos
BR112018000236A2 (pt) composições nutricionais e métodos para a promoção do desenvolvimento cognitivo
WO2019011955A3 (de) Solubilisat mit curcumin und optional zumindest einem weiteren wirkstoff
BRPI0410267A (pt) composições contendo enzimas, produtos alimentares dietéticos e medicamentos produzidos das mesmas e sua utilização para fins medicinais
BR112021025056A2 (pt) Mistura de extratos de planta para uso na prevenção e/ou tratamento de doenças intestinais inflamatórias crônicas
BR112018069727A2 (pt) métodos de tratamento com vitamina d
BR112019010057A2 (pt) composição, método para suprimir a ingestão de comida, sequência de shrna, método de inibição da síntese de ácidos graxos
MX2021013285A (es) Uso de cannabidiol en el tratamiento del complejo de esclerosis tuberosa.
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
BR112023000264A2 (pt) Método para aumentar a população de coprococcus spp. no microbioma intestinal
BR112023000326A2 (pt) Método para aumentar a população de dialister spp. no microbioma intestinal
BR112017019480A2 (pt) dosagem unitária de composição vitamínica ampliável, e, método para tratar uma deficiência de vitamina lipossolúvel.
Mishra et al. Healthy life style practices to combat COVID-19 pandemic–A mini review
Sutili et al. Clove Oil, eugenol effective anesthetics for silver catfish, other Brazilian species
WO2019040459A3 (en) Composition and nutritional supplement made therefrom
Nick The connection between Lyme disease, an Inflamed Brain (Sickness Syndrome), and Fibromyalgia Syndrome
BR112023017603A2 (pt) Método para aumentar a população de blautia spp. no microbioma intestinal